Previous studies have shown a significant downregulation of PDHA1 expression in breast cancer [38], ovarian carcinoma [39], and gastric cancer [40] resulting in enhanced glycolysis and an association with poor prognosis. The gene discussed is PDHA1; the disease is breast carcinoma.